Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer Loses U.K. Patent Appeal Over $4.8 Billion Lyrica Drug
Pfizer Loses U.K. Patent Appeal Over $4.8 Billion Lyrica Drug
Pfizer Loses U.K. Patent Appeal Over $4.8 Billion Lyrica Drug
Submitted by
admin
on October 13, 2016 - 10:59am
Source:
Bloomberg
News Tags:
Pfizer
UK
patents
Lyrica
Allergan
Actavis
Headline:
Pfizer Loses U.K. Patent Appeal Over $4.8 Billion Lyrica Drug
Do Not Allow Advertisers to Use My Personal information
